INTRODUCTION {#SEC1}
============

Methods and tools for computational proteomics data analysis evolve constantly in order to match rapid advances in proteomics and enabled by them large scale efforts aiming to profile biological systems at the protein level ([@B1]). In this context, many methods and data processing tools have been developed for the identification and quantification of peptides and proteins from biological samples using mass spectrometry-based approaches ([@B4]). Further downstream analysis is subsequently performed to facilitate biological interpretation of such obtained quantitative results, with its own distinct set of challenges ([@B6]), and an interdependent ecosystem of databases, tools and resources for proteomics research ([@B7]).

Increasingly, proteomic profiling efforts involve identification and quantification of specific proteoforms that may exhibit distinct activities and functions, including those resulting from protein post-translational modifications (PTMs) ([@B8]). The importance of protein phosphorylation, acetylation, methylation and other PTMs that are involved in essential cellular processes has led to the development of databases and tailored resources, such as PhosphositePlus ([@B9]), Phospho.ELM ([@B10]) and PhosphoPep ([@B11]) for phospho-proteomics, as well as comprehensive databases of PTMs and aggregators of related functional annotations, such as iPTMnet ([@B12]), dbPTM ([@B13]) or SIGNOR ([@B14]).

This contribution introduces a web server for both interactive and programmatic analysis and visualization of peptide and protein level proteomic data, with special emphasis on PTMs. The new tool, dubbed piNET, aims to facilitate mapping, annotation and analysis of post-translational modification sites, as well as modifying enzymes that target these sites in the context of biological pathways. As illustrated in Figure [1](#F1){ref-type="fig"}, piNET integrates iPTMnet (Protein Information Resource), PhosphoSitePlus, SIGNOR and other proteomic resources with PTM network analysis, while making use of a fast approach for peptide mapping and a custom D3 library for versatile visualization.

![The overall flowchart of piNET proteoform-centric mapping, annotation and visualization workflow.](gkaa436fig1){#F1}

Furthermore, piNET connects proteomics profiles with transcriptional and proteomics signatures generated by The Library of Integrated Network-based Cellular Signatures (LINCS) project ([@B15]), which aims to systematically collect Omics signatures of genetic and chemical perturbations, including signatures induced by genetic knock-downs or small molecule inhibitors of the modifying enzymes, such as kinases. By seamless integration with Enrichr ([@B16],[@B17]), iLINCS (<http://ilincs.org>) and related tools that facilitate interaction with the LINCS library of signatures, one can apply the Connectivity Map approach ([@B18]) in order to gain further mechanistic insights into signalling cascades potentially driving the underlying biological states and their proteomics signatures.

MATERIALS AND METHODS {#SEC2}
=====================

piNET has been implemented as a modular web server, using the Spring-Boot JAVA platform in conjunction with state-of-the-art D3 JavaScript libraries and their in-house developed extensions for highly customizable visualization. As a result, piNET can be executed within the browser and does not require installing additional plugins or applications. Programmatic access to piNET workflows is enabled through the corresponding RESTful Application Programming Interface (API) methods. Documentation and help pages illustrate piNET workflows and the use of APIs with realistic examples, including Python scripts that invoke these respective APIs and embed the results in the json format into other applications.

piNET integrates several databases and resources for proteomics studies (see Table [1](#tbl1){ref-type="table"}) in order to streamline mapping, annotation and analysis of post-translational modification sites, as well as modifying enzymes that target these sites. Multiple definitions of PTMs can be used interchangeably, including shorthand notation (e.g., pS, aK), mass difference (DeltaMass) identified experimentally, or PTM ontologies, including PsiMOD (<https://www.ebi.ac.uk/ols/ontologies/mod>) and UniMOD (<http://www.unimod.org>). As part of the initial processing of input peptide/PTM lists, using a Pride-MOD utility ([@B19]) and in-house developed translation modules, PTMs are mapped into PsiMOD and UniMOD entries. Such unified encoding can be used, in conjunction with mapping into proteins, as a basis for generating unique proteoform identifiers (provisionally implemented in the form of Protein Line Notation tokens).

###### 

The list of databases and resources integrated in piNET with the goal of providing an easy to use and intuitive interface for the analysis and visualization of proteomics data. Plus signs are used to indicate components available as part of each of the resources listed

  Name              Web site                                          PTM mapping & annotations   Pathways & perturbations
  ----------------- ------------------------------------------------- --------------------------- --------------------------
  UniProt           <https://www.uniprot.org>                         \+                          
  PsiMOD            <https://www.psidev.info/MOD>                     \+                          
  PROSITE           <https://prosite.expasy.org>                      \+                          
  PhosphoSitePlus   <https://www.phosphosite.org/>                    \+                          \+
  iPTMnet           <http://proteininformationresource.org/iPTMnet>   \+                          \+
  Signor            <http://signor.uniroma2.it>                       \+                          \+
  DeepPhos          <https://github.com/USTC-HIlab/DeepPhos>          \+                          \+
  iLINCS            <https://ilincs.org/>                                                         \+
  Enrichr           <https://amp.pharm.mssm.edu/Enrichr>                                          \+
  Reactome          <https://reactome.org>                                                        \+

piNET can be used to query UniProt or Prosite APIs in order to map peptides and PTM sites into proteins from well annotated and continuously updated proteomes available through these authoritative resources ([@B20]). However, for fast mapping of large sets of peptides and PTMs, a locally indexed version of the UniProtKB/Swiss-Prot and TrEMBL protein sequence databases for a number of commonly used organisms, including *homo sapiens* and *mus musculus* (please refer to piNET for a complete list of organisms), has also been implemented using the state-of-the-art Apache Lucene indexing by Chen *et al.* ([@B23]). Using this fast peptide matching approach, an average search time of 0.02 s per peptide has been observed in our tests for a random sample of 20 000 peptides of length 10.

In addition, in order to overcome the limitations on the total number of peptides that can be submitted directly due to the maximum length of the URL, a file upload mode can be used to submit large sets of peptides and PTMs (with their abundance values), using either the MaxQuant evidence file or a generic multi-column csv format. This option also enables submission of datasets with proteomic profiles of multiple samples and meta-data descriptors to define groups of samples, with the goal of deriving a protein or peptide level differential expression signature for further analysis. Volcano plots can be generated in this workflow to guide the choice of differentially expressed peptides/PTMs/protein moieties based on the analysis of the effect size (fold change) and statistical significance (t-test based *P*-values).

Furthermore, piNET mines iPTMnet, PhosphoSitePlus, and SIGNOR for functional annotations of PTMs, and integrates these annotations to identify kinases and other modifying enzymes that are experimentally known to target PTM sites involved, and as a basis for PTM network analysis and visualization. For kinases, in addition to known modifier-PTM site pairs, a well performing method developed recently using deep learning, DeepPhos ([@B24]) is used to generate predicted kinase-PTM site pairs. These predictions are further augmented by sequence-based mapping of sites that share a high degree of motif similarity with known target sites, using PhosphoSitePlus known target sequences and consensus motif definition. piNET modular annotation and visualization engines can be extended to include other representative methods for the prediction of kinase-substrate pairs and related resources ([@B25]), such as NetworKIN ([@B27]), in order to further expand kinome annotations.

Finally, piNET connects protein level signatures with transcriptional and proteomics signatures generated by the LINCS project ([@B30]). A simple signature consisting of a set of up- and down-regulated proteins can be first compared with a large set of LINCS mRNA level signatures as readily available proxies by utilizing the aforementioned Enrichr APIs to generate the results of enrichment analysis, with emphasis on gene sets consisting of gene up- and/or down-regulated in response to kinase loss or gain of function, and thus representing kinase gain or loss of function signatures. Furthermore, piNET uses iLINCS APIs to connect protein level relative or differential expression profiles (differential abundance vectors) either with LINCS mRNA level signatures as a proxy, or directly with proteomics signatures generated by the LINCS projects, including those induced by the loss or gain of function of relevant modifying enzymes (when available). It should be stressed, however, that the overall number of proteomics signatures generated by the LINCS project is much smaller compared to transcriptional profiling ([@B30]).

RESULTS {#SEC3}
=======

piNET provides an intuitive and easy to use interface, divided into modular workflows. Several use cases, including those stemming from the LINCS project, are incorporated as examples in order to illustrate piNET functionality, network-based visualization and integration with biological domain knowledge. We are also using these use cases to illustrate potential pitfalls, such as those related to the problem of projecting proteoform level data onto gene level in order to facilitate pathway and other functional analyses. Strategies to overcome these limitations are also discussed.

Peptide to protein workflow {#SEC3-1}
---------------------------

As the first step in downstream analysis, piNET can be used to annotate, map and analyze a set of peptide moieties, including those with post-translational modifications. Starting from a set of peptides, and optional modifications within those peptides, piNET provides mapping into both canonical and other isoforms included either in the UniProtKB/Swiss-Prot and/or TrEMBL databases. piNET also provides mapping and harmonization of PTM meta-data, using PsiMOD and UniMOD ontologies, and generating Protein Line Notation tokens to represent each peptide moiety with modifications for automated annotation exchange systems. Mapping of peptides and PTM sites into proteins and genes is summarized as intuitive interactive graphs and tables that can be downloaded, or alternatively generated using API calls for integration with other resources. An example of a graphical summary of peptide to protein to PTM mapping is shown in Figure [2](#F2){ref-type="fig"} for a subset of P100 phospho-peptides ([@B31]) that are being used to profile responses to cellular perturbation by the LINCS project. Submissions and updates in the first workflow (peptide to protein tab) are automatically propagated to the subsequent workflows, while offering several options for aggregating peptide level data into protein level abundance data, including averaging peptide abundance values for peptides mapping into a protein, while ignoring peptides mapping into multiple proteins.

![Peptide to protein to gene mapping for a subset of P100 representative phospho-peptides with PTM modification sites mapped into the corresponding protein and gene entities. Note that some peptides match multiple proteins and/or genes (many to many mapping), as indicated by thick blue edges for the highlighted peptides.](gkaa436fig2){#F2}

PTM to modifying enzyme workflow {#SEC3-2}
--------------------------------

This PTM-centric workflow aims to elucidate signaling cascades converging on PTM sites by mapping known and predicted upstream enzymes that target those PTM sites. An interactive and high resolution PTM-centric network views are provided by embedding PhosphoSitePlus, iPTMnet and SIGNOR databases of enzyme-substrate relationships. For phosphorylation, known kinase - target phospho sites are derived from PhosphoSitePlus ([@B9]) to provide a site specific PTM-centric kinome network view, and shed light onto phosphorylation cascades that may be involved. On the other hand, iPTMnet provides comprehensive mapping and annotation of both kinase---phosphopeptide pairs (which largely overlaps with that of PhosphoSitePlus), as well as other modifying enzymes and their targets ([@B12]). Finally, SIGNOR can be used in piNET to map carefully curated causal relationships, available for over 2800 human proteins participating in signal transduction. Specifically, PTMs causing a change in protein concentration or activity have been curated and linked to the modifying enzymes ([@B14]).

The enzyme-substrate relations can be visualized using highly customizable interactive graphs that capture biological entities and relationships potentially associated with the observed patterns in protein expression profiles. For example, the casual relationships extracted from SIGNOR can be represented as edges in the graph, using the color of an edge to indicate the activation/inactivation relationships between signalling entities. A bipartite graph view for P100 kinome network, using SIGNOR causal relationships, is illustrated in Figure [3](#F3){ref-type="fig"}. The moieties that are being quantified in a proteomic assay (here P100 phospho-peptides with their *Z*-score transformed normalized abundance values) are shown as nodes in the right column, while the modifying enzymes that target these PTMs in the left column. When quantitative peptide or protein abundance data are given, the abundance levels of peptide/PTM/protein moieties are represented by the color of a node, with yellow corresponding to high relative abundance and blue to low relative abundance, respectively. Such views provide a visual representation of relationships between peptide/PTM/protein moieties and their abundance profiles, and other relevant biological entities or processes.

![Functional annotation and visualization of a PTM network for a set of P100 phospho-peptide probes using curated causal annotations from SIGNOR, overlaid with a representative P100 expression (abundance) profile for a non-specific kinase inhibitor, staurosporin, generated as part of the LINCS project. The *Z*-score transformed relative abundance of P100 phospho-peptides in the right column is indicated by the color of nodes: blue for lower (down-regulated sites) and yellow for higher (up-regulated sites) than average, respectively. Note that P100 phospho-sites and their known modifiers (or regulators) are connected using red or blue edges for positive (or activating) versus negative (or inactivating) relationships, respectively. The modifying enzymes (kinases) in the left column are shown as red nodes, whereas other type of regulators, such as those involved in protein-protein interactions, are shown as black nodes.](gkaa436fig3){#F3}

Protein to pathway & perturbation workflow {#SEC3-3}
------------------------------------------

A set of peptides (with PTMs) and the associated (differential) abundance values can be projected onto the protein (and thus gene) level for the purpose of further pathway analysis and visualization. Peptides matching multiple proteins can be ignored at that stage, while the geometric average is used to assign per protein value for multiple peptides matching the same protein. However, several other options to map peptide level abundance values into proteins are also available. In addition, the user can directly specify per protein values when submitting protein level profiles in the Protein2Pathway tab. Subsequently, piNET can be used to facilitate pathway enrichment analysis with Enrichr, and to perform further mapping into Reactome pathways for interactive exploration, while generating high resolution visualization and tabulated results.

Since PTMs mediate cell growth, death and differentiation through intracellular signal transduction cascades and the resulting transcriptional changes, gene and protein expression signatures and the signature connectivity analysis can potentially be used to derive useful information and mechanistic insights. LINCS provides a large library of transcriptional and proteomic signatures measured in response to molecular, genetic and disease perturbations, including the loss of function (due to genetic KDs and small molecule inhibitors) of modifying enzymes. To capitalize on this resource, piNET can be used to analyze protein level data in conjunction with LINCS signatures of cellular perturbations, by using iLINCS APIs or exploring the results interactively in iLINCS (<http://ilincs.org>). An example of connectivity analysis for a user provided input L1000 signature (of a multi-targeted kinase inhibitor midostaurin) is shown in Figure [4](#F4){ref-type="fig"}, with other strongly concordant or discordant LINCS signatures connected by edges in the circos plot. Note that other related kinase inhibitors are identified, suggesting overlapping kinase targets.

![Connectivity analysis for a user provided input signature (here L1000 signature of a multi-targeted kinase inhibitor midostaurin), represented by the gray node in the figure. Strongly connected LINCS signatures of chemical perturbations, including midostaurin in different cell lines and related drugs, are shown in red for positive and blue for negative correlations, respectively. For each perturbation, the name of the compound and the cell line used are indicated in the labels. The shade of the node represents the strength of correlation (darker shades corresponding to higher correlations squared), whereas the size of the node represents its statistical significance (*P*-values computed by iLINCS).](gkaa436fig4){#F4}

DISCUSSION {#SEC4}
==========

Downstream analysis and visualization of MS-based proteomic data is essential for biological interpretation. However, this process poses challenges to most biologists. Several excellent software tools to facilitate downstream analysis have been developed by the proteomic community, including Perseus ([@B31]), PeptideShaker ([@B32]) and Scaffold ([www.proteomesoftware.com](http://www.proteomesoftware.com)). However, these are standalone software packages that require installation (and for Scaffold, purchasing a licence key), and have dependencies (e.g. on specific libraries) that can represent a significant barrier for adoption among biologists. Importantly, these stand-alone tools do not provide a programmatic interface for integration with other resources, and instead need to be integrated with local data processing pipelines.

piNET has been designed to provide an integrated web platform for analysis, interpretation and visualization of large-scale proteomics data. To that end, piNET enables fast peptide/PTM to protein mapping, harmonization of meta-data pertaining to PTMs, systematic PTM to modifying enzyme mapping and other functional annotations, coupled with high quality visualization of PTM networks and protein pathways. We believe that piNET adds significantly to the ecosystem of tools for downstream proteomic data analysis by integrating these individual components and annotation resources, by coupling them with a high quality visualization engine, and by making annotation and analysis workflows available as API methods for easy integration with other tools and resources for proteomics. To the best of our knowledge, there are no web-based tools that enable fast, large-scale mapping of peptides and PTMs, integrated with subsequent PTM network and signature connectivity analyses for biological insights. However, we would like to recognize another peptide-centric web tool for MS-based proteomics data analysis, namely Pathway Palette ([@B33]) that uses a client-server architecture to provide mapping from peptides to biological pathways.

Since protein pathway activation (either through a higher protein expression or PTM, for instance) often leads to transcriptional and proteomic signatures downstream from signalling cascades, one can use connectivity map approach ([@B18]) to provide additional mechanistic insights, e.g. by identifying likely modifying enzymes with concordant gain of function or discordant loss of function signatures. piNET can be used to connect user provided (or computed on-the-fly from a quantitative proteomic dataset) relative or differential protein expression signatures with the LINCS library of chemical and genetic perturbation signatures, as illustrated in Figure [4](#F4){ref-type="fig"}. However, several inherent limitations of this approach must also be considered, including the fact that most of the LINCS perturbation profiling has been in fact performed at the transcriptional level, using the L1000 landmark gene set, and to a smaller degree, at the proteomics level using targeted assays, such as P100 phospho-proteomic and GCP global chromatin profiling ([@B30],[@B34]). Consequently, the relevant perturbations may not have been profiled at the protein level, or the overlap between peptide and protein moieties from user defined and LINCS proteomics profiles may be too small for reliable connectivity analysis. At the same time, the utility of using mRNA levels as a proxy for proteomics signatures can be limited. Although widely used when considering which pathways or biological processes could be involved, this step constitutes an approximation, especially in the case of PTMs. Therefore, proper care needs to be applied to interpret the results.

In this regard, we would like to comment that the LINCS and related data generation efforts are on-going, and we expect the number of signatures available for such analyses to grow over time. We also aim to further integrate piNET and its visualization engine with the recently published PTMsigDB that enables PTM-Signature Enrichment Analysis (PTM-SEA) of phosphoprotein signature data ([@B35]), and thus should alleviate some of the above-mentioned limitations as well.

We would like to thank the developers of tools and resources for proteomics integrated into piNET, for making their software packages, web servers and API methods available to the community. We would like to acknowledge our early users, especially Drs. Rob McCullumsmith, Ken Greis, Michael Wagner and their groups, members of the BD2K-LINCS Data Coordination and Integration Center, as well as LINCS consortium participants, for their feedback and encouragement.

FUNDING {#SEC5}
=======

National Institutes of Health \[U54 HL127624, P30 ES006096, R01 MH107487, 1T32CA236764, UL1TR001425, U01GM120953, in part\]. Funding for open access charge: National Institutes of Health.

*Conflict of interest statement*. None declared.
